Rimexolone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a606003 |
| Pregnancy category |
|
| Routes of administration | ocular |
| Identifiers | |
| CAS Number |
49697-38-3 |
| ATC code | H02AB12 (WHO) S01BA13 |
| PubChem | CID 5311412 |
| IUPHAR/BPS | 7099 |
| DrugBank |
DB00896 |
| ChemSpider |
4470902 |
| UNII |
O7M2E4264D |
| KEGG |
D05729 |
| ChEMBL |
CHEMBL1200617 |
| Chemical data | |
| Formula | C24H34O3 |
| Molar mass | 370.525 g/mol |
| |
| |
| | |
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.
References
- ↑ Kavuncu S, Horoz H, Ardagil A, Erbil HH (August 2008). "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery". Int Ophthalmol 28 (4): 281–5. doi:10.1007/s10792-007-9131-0. PMID 17762913.
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
